Stryker (NYSE:SYK – Free Report) had its target price boosted by Piper Sandler from $375.00 to $380.00 in a research note published on Wednesday morning, Benzinga reports. They currently have an overweight rating on the medical technology company’s stock. Several other research analysts also recently commented on the stock. Canaccord Genuity Group upgraded shares of […]